We are live on ! Find out more
QNRX

Quoin Pharmaceuticals
QNRX

3 hedge funds and large institutions have $383K invested in Quoin Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

50% more funds holding

Funds holding: 2 → 3 (+1)

0% less ownership

Funds ownership: 0% → 0% (-0%)

59% less capital invested

Capital invested by funds: $937K → $383K (-$554K)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$903K
2
Renaissance Technologies
Renaissance Technologies
New York
+$387K
3
TSS
Two Sigma Securities
New York
+$129K

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$240K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$198K +$903K +21 New
Renaissance Technologies
2
Renaissance Technologies
New York
$152K +$387K +9 +129%
TSS
3
Two Sigma Securities
New York
$29K +$129K +3 New
Bank of America
4
Bank of America
North Carolina
$4K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
– -$240K -2 Closed

QNRX Hedge Fund Activity: Q4 2021 in Review

3 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q4 2021, worth a combined $383K — down 59% from $937K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new QNRX positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $903K. The largest seller was Geode Capital Management, exiting entirely with an estimated $240K sold.

  • 3 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q4 2021, up from 2 in Q3 2021.
  • Funds reported $383K of Quoin Pharmaceuticals stock for Q4 2021, down 59% quarter-over-quarter.
  • 2 funds opened new Quoin Pharmaceuticals positions in Q4 2021 and 1 closed out, a net change of +1 holder.
  • The largest Quoin Pharmaceuticals buyer in Q4 2021 was Morgan Stanley, an estimated $903K added.
  • The largest Quoin Pharmaceuticals seller in Q4 2021 was Geode Capital Management, an estimated $240K sold.

Based on aggregated 13F filings for Q4 2021.